UA86076U - Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type - Google Patents

Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Info

Publication number
UA86076U
UA86076U UAU201308057U UAU201308057U UA86076U UA 86076 U UA86076 U UA 86076U UA U201308057 U UAU201308057 U UA U201308057U UA U201308057 U UAU201308057 U UA U201308057U UA 86076 U UA86076 U UA 86076U
Authority
UA
Ukraine
Prior art keywords
meldonium
phosphate
left ventricle
impairment
heart disease
Prior art date
Application number
UAU201308057U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Иван Иванович Когутич
Иван Антонович Яворский
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201308057U priority Critical patent/UA86076U/en
Publication of UA86076U publication Critical patent/UA86076U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)

Abstract

The method for assessing the efficacy of Meldonium phosphate in treating the ischemic heart disease with angina pectoris and arterial hypertension with the impairment of the diastolic function of the left ventricle according to hypertrophic type provides for the comparison of the state of patient prior to and after the treatment. Prior to the treatment with Meldonium phosphate, Doppler-echocardiography is performed at rest and the transmitral blood flow is measured based on the rate of the early diastolic filling. The analogous procedures are performed after the treatment with Meldonium phosphate. If the rate of the early diastolic filling in the left ventricle increases by at least 10.2 % as compared with that prior to the treatment, the hemodynamic result and the antianginal effect are considered as the positive ones.
UAU201308057U 2013-06-25 2013-06-25 Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type UA86076U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201308057U UA86076U (en) 2013-06-25 2013-06-25 Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201308057U UA86076U (en) 2013-06-25 2013-06-25 Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Publications (1)

Publication Number Publication Date
UA86076U true UA86076U (en) 2013-12-10

Family

ID=52285649

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201308057U UA86076U (en) 2013-06-25 2013-06-25 Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Country Status (1)

Country Link
UA (1) UA86076U (en)

Similar Documents

Publication Publication Date Title
UA86076U (en) Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA86077U (en) Method for assessing efficacy of inosine in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA81783U (en) Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA80784U (en) Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA81645U (en) Method for assessing efficacy of efonidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71695U (en) Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71709U (en) Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71708U (en) Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA62810U (en) Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71706U (en) Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA101654U (en) Method for assessment of olmesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA100785U (en) Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
UA100786U (en) Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA79251U (en) Method for assessing efficacy of aranidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA62176U (en) Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71703U (en) Method for assessing efficacy of atorvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA91678U (en) Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA78726U (en) Method for assessing efficacy of telmisartan in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA59416U (en) Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA68461U (en) Method for assessing efficacy of s-amlodipine in treating ischemic heart disease with angina and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA56814U (en) Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA70705U (en) Method for assessing efficacy of isosorbid dinitrate in treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA55225U (en) method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type